Table 10 An assessment of the changes in urine volume and color affected by the 90-day oral administration of 23%-GNANA, a test substance to the male and female rats (n=10)
Tests | Groups (mg/kg/day)a) |
G1 (0)% | G2 (1,250) | G3 (2,500) | G4 (5,000) |
Male | Female | Male | Female | Male | Female | Male | Female |
Volume (mL) | 12.8±1.89* | 9.0±2.24* | 11.4±3.23 | 9.2±4.34 | 12±2.74 | 7.8±4.15 | 17.1±2.25 | 9.8±3.98 |
Color-yellow | 5* | 5* | 5 | 5 | 5 | 5 | 5 | 5 |
No. of animals | 5* | 5* | 5 | 5 | 5 | 5 | 5 | 5 |
*: Represents a significant difference at p<0.05 level compared with the vehicle control.
%: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day), High-dose group (G4: 5,000 mg/10 mL/day)